Islande -
islandais -
LYFJASTOFNUN (Icelandic Medicines Agency)
klexane stungulyf, lausn áfyllt sprauta 100 mg/ml
sanofi-aventis norge as - enoxaparinum natricum inn - stungulyf, lausn - áfyllt sprauta 100 mg/ml
Islande -
islandais -
LYFJASTOFNUN (Icelandic Medicines Agency)
remurel (brabio 20 mg/ml stungulyf, lausn í áfylltri sprautu) stungulyf, lausn í áfylltri sprautu 20 mg/ml
zentiva k.s.* - glatiramer acetat - stungulyf, lausn í áfylltri sprautu - 20 mg/ml
Islande -
islandais -
LYFJASTOFNUN (Icelandic Medicines Agency)
boostrix stungulyf, dreifa áfyllt sprauta
glaxosmithkline pharma a/s - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid - stungulyf, dreifa - áfyllt sprauta
Islande -
islandais -
LYFJASTOFNUN (Icelandic Medicines Agency)
boostrix polio stungulyf, dreifa áfyllt sprauta
glaxosmithkline pharma a/s - diphtheria toxoid; tetanus toxoid; pertussis toxoid; filamentous haemagglutinin; pertactin; poliovirus inactivated type 1; poliovirus inactivated type 2; poliovirus inactivated type 3 - stungulyf, dreifa - áfyllt sprauta
Islande -
islandais -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu með nálarvörn 12.500 and-xa a.e.
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu með nálarvörn - 12.500 and-xa a.e.
Islande -
islandais -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu með nálarvörn 7.500 and-xa a.e.
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu með nálarvörn - 7.500 and-xa a.e.
Islande -
islandais -
LYFJASTOFNUN (Icelandic Medicines Agency)
copaxone stungulyf, lausn í áfylltri sprautu 40 mg/ml
teva gmbh - glatiramer acetat - stungulyf, lausn í áfylltri sprautu - 40 mg/ml
Islande -
islandais -
LYFJASTOFNUN (Icelandic Medicines Agency)
influvactetra (influvac tetra) stungulyf, dreifa í áfylltri sprautu 15/15/15/15 míkróg/skammt
viatris aps - b/phuket/3073/2013-líkur stofn (b/phuket/3073/2013, villigerð); a/victoria/2570/2019 (h1n1)pdm09 - líkur stofn (a/victoria/2570/2019, ivr-215); a/darwin/9/2021 (h3n2)- líkur stofn (a/darwin/9/2021, san-010); b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) - stungulyf, dreifa í áfylltri sprautu - 15/15/15/15 míkróg/skammt
Islande -
islandais -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu 15.000 anti-xa iu
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu - 15.000 anti-xa iu
Islande -
islandais -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu 5.000 anti-xa iu
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu - 5.000 anti-xa iu